Rivian (RIVN.US) reported fourth quarter vehicle production and deliveries that topped the average estimates of analysts surveyed by Bloomberg. The company's shares are currently gaining more than 5% in pre-market trading on Wall Street.
- Production 12,727 vehicles, estimates 11,458
- Vehicles delivered 14,183, estimates 13,402
On a full-year 2024 basis, the company produced 49,476 vehicles and delivered 51,579 vehicles. The results were in line with management's projections for full-year 2024, which called for production of 47,000 to 49,000 vehicles and delivery of 50,500 to 52,000 vehicles. The company will present its final Q4 report on February 20 this year.
The company's shares are gaining more than 5% before the opening of the session on Wall Street and are trading in the $14 per share zone.
Source: xStation
STMicroelectronics shares down 14% amid mixed future outlook📉
Stock of the Week - Merck & Co Inc (23.10.2025)
Beyond Meat after the sell-off📉Is short squeeze still possible?
Banco Macro gains 5% amid US Treasury help to Argentine peso 🗽
The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.
